HOLX - Hologic, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
38.85
+0.23 (+0.60%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close38.62
Open38.52
Bid0.00 x 0
Ask0.00 x 0
Day's Range38.25 - 38.87
52 Week Range35.33 - 46.80
Volume872,005
Avg. Volume2,551,541
Market Cap10.743B
Beta0.85
PE Ratio (TTM)10.28
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Can Hologic (HOLX) Diagnostics Growth Recur in Q2 Earnings?
    Zacks3 days ago

    Can Hologic (HOLX) Diagnostics Growth Recur in Q2 Earnings?

    A strong Panther system and an increasing utilization of Aptima women's health assays add stimulus to Global growth within Hologic's (HOLX) molecular diagnostics.

  • Can Business Services Aid athenahealth's (ATHN) Q1 Earnings?
    Zacks7 days ago

    Can Business Services Aid athenahealth's (ATHN) Q1 Earnings?

    athenahealth's (ATHN) strong product portfolio, network expansion strategies and unique business model are likely to drive Q1 earnings.

  • 4 MedTech Stocks to Keep in Good Books This Earnings Season
    Zacks7 days ago

    4 MedTech Stocks to Keep in Good Books This Earnings Season

    Considering the ageing population, changing market dynamics, upbeat consumer sentiment and increased business investments, the Medical-Device sector appears to be in pink of health.

  • Benzinga8 days ago

    Hologic's SculpSure Body Contouring Treatment Scores Distribution Win

    The hair and skin cosmetic procedure provider LightRx Face & Body announced a partnership Tuesday in which it will provide Hologic, Inc. (NASDAQ: HOLX )'s SculpSure non-invasive laser body contouring treatment ...

  • Thomson Reuters StreetEvents16 days ago

    Edited Transcript of HOLX presentation 6-Mar-17 9:35pm GMT

    Hologic Inc at Raymond James Institutional Investors Conference

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit16 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 14. Over the last one-month, outflows of investor capital in ETFs holding HOLX totaled $14.78 billion.

  • Can HOLX Stock Rebound from Its Recent Lows?
    Market Realist22 days ago

    Can HOLX Stock Rebound from Its Recent Lows?

    Investor Update: Hologic's Recent Partnerships, Product Launches

  • Wall Street Largely Bullish on Hologic Stock in March
    Market Realist22 days ago

    Wall Street Largely Bullish on Hologic Stock in March

    Investor Update: Hologic's Recent Partnerships, Product Launches

  • Hologic and Dexalytics Partner to Develop Software for Athletes
    Market Realist22 days ago

    Hologic and Dexalytics Partner to Develop Software for Athletes

    On February 22, 2018, Hologic (HOLX) announced that it has entered into an agreement with the University of Minnesota to be an exclusive provider of Dexalytics: Teams software in North America. The partnership is aimed at providing groundbreaking body composition analysis software to the sports science and human performance industry. The software harnesses the body composition data provided by the DXA (dual X-ray absorptiometry) scans and compares them with the predetermined standards specific to the sport and position.

  • Hologic’s Viera Expected to Be Key Growth Driver for 2018
    Market Realist22 days ago

    Hologic’s Viera Expected to Be Key Growth Driver for 2018

    Hologic’s (HOLX) Viera system is a one-of-a-kind wireless, handheld breast ultrasound system. On February 28, 2018, Hologic announced that it will present its Viera system at the annual ECR (European Congress of Radiology) in Vienna along with seven of its other market-leading breast and skeletal health innovations. The list includes the company’s fastest and highest resolution breast tomosynthesis system, the 3Dimensions Mammography System, which was launched in Europe in September 2017.

  • Philips and Hologic Partners in Women’s Health Area
    Market Realist22 days ago

    Philips and Hologic Partners in Women’s Health Area

    On March 2, 2018, Hologic (HOLX) announced a global partnership with Royal Philips (PHG) to provide an integrated health solution for women comprised of diagnostic imaging modalities and advanced informatics along with screening, diagnosis, and treatment services. According to the agreement, some of the selected products from Hologic’s breast health portfolio will be available for Royal Philips to offer as part of its multi-modality deals for healthcare providers, hospitals, and more. The selected products include Hologic’s breast screening technologies, interventional radiology technologies, and its 3Dimensions Mammography System, the fastest breast tomosynthesis system in the market.

  • Hologic Gets FDA Approval for Its New 3D Imaging Technology
    Market Realist22 days ago

    Hologic Gets FDA Approval for Its New 3D Imaging Technology

    On March 27, 2018, Hologic (HOLX) announced that its Clarity HD (high-definition) high-resolution 3D (three-dimensional) imaging and Intelligent 2D (two-dimensional) imaging technology has been approved by the FDA. The technologies are available for use on the company’s 3Dimensions Mammography System, the highest-resolution, fastest breast tomosynthesis system available in the market. Hologic’s 3Dimensions Mammography System was approved by the FDA in 2011.

  • Zacks Small Cap Research23 days ago

    ICAD: Q4 2017 Results: Tomo Seeing “Strong Demand”. Plug Pulled on Unprofitable Skin Subscription Biz

    Revenue, particularly in the Detection segment, continued to impress with very strong sales of the tomo (2D and 3D) products pushing total revenue up by 14% yoy. Detection product sales, up 100% yoy (pro-forma for ex-MRI), turned in the best quarter since Q3 2011 (when ICAD was still direct-selling MRI software) and crushed our number by 25%. While Q4 is typically ICAD’s strongest, the apparent accelerating adoption of the ‘legacy’ 2D and first-gen 3D tomo (GE-only) applications is obviously encouraging, particularly given the near-term launch of ICAD’s next-gen software.

  • 3 Top Healthcare Stocks to Buy Right Now
    Motley Fool27 days ago

    3 Top Healthcare Stocks to Buy Right Now

    When the market provides you with the opportunity to buy a strong business in a critical industry at a reasonable price, it's worth considering.

  • Hologic's Clarity HD & Intelligent 2D Systems Gain FDA Nod
    Zacks28 days ago

    Hologic's Clarity HD & Intelligent 2D Systems Gain FDA Nod

    Hologic (HOLX) forges ahead with initiatives to boost the Breast Health business.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Hologic Inc.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 14. Over the last one-month, outflows of investor capital in ETFs holding HOLX totaled $2.71 billion.

  • Should Value Investors Consider Hologic (HOLX) Stock Now?
    Zackslast month

    Should Value Investors Consider Hologic (HOLX) Stock Now?

    Hologic (HOLX) appears to be a good choice for value investors right now, given its favorable P/E and P/S metrics.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Hologic Inc.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 14. Index (PMI) data, output in the Healthcare sector is rising.

  • Hologic (HOLX) Down 4.5% Since Earnings Report: Can It Rebound?
    Zackslast month

    Hologic (HOLX) Down 4.5% Since Earnings Report: Can It Rebound?

    Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 14. Over the last one-month, outflows of investor capital in ETFs holding HOLX totaled $16.97 billion.

  • Hologic Rival Cites Abuse in $4 Billion Breast-Screening Sector
    Bloomberg2 months ago

    Hologic Rival Cites Abuse in $4 Billion Breast-Screening Sector

    Hologic Inc.’s control of the market for 3D breast imaging in cancer screening is based on misuse of its patents and litigation, Fujifilm Holdings Corp. said in a lawsuit accusing its bigger rival of antitrust ...

  • Hologic's Alliance With Philips to Boost Breast Health Unit
    Zacks2 months ago

    Hologic's Alliance With Philips to Boost Breast Health Unit

    Hologic (HOLX) is consistently trying to fortify its Breast Health segment.

  • Here's Why You Must Add Hologic (HOLX) to Your Portfolio Now
    Zacks2 months ago

    Here's Why You Must Add Hologic (HOLX) to Your Portfolio Now

    Hologic's (HOLX) GYN Surgical business boasts huge future prospects. Also, the recent commercial launch of MyoSure MANUAL device in the United States looks promising.

  • Hologic Banks on Diagnostics, GYN Surgical Prospects Bright
    Zacks2 months ago

    Hologic Banks on Diagnostics, GYN Surgical Prospects Bright

    Hologic (HOLX) stays upbeat about GYN Surgical on the recent commercial launch of MyoSure MANUAL device in the United States.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 14. Index (PMI) data, output in the Healthcare sector is rising.